Dow Chemical DOW
Dow Inc. reports $11.27B revenue
- Form
- 10-Q
- Filed
- Importance
- Notable
- Accession
- 0001751788-26-000160
- Revenue: $11.27 billion for Q3 2026
- Net income: $458 million for Q3 2026
- Diluted EPS: $0.62 for Q3 2026
- Cash and equivalents: $4.14 billion as of Sep 30, 2026
Written from the 10-Q on EDGAR. Check the filing before you rely on it.
What changed since last quarter
3 new legal mentions
Compared with the 10-Q for the period ended Jun 30, 2026.
New legal mentions (3)
- The credit for income taxes for the three months ended September 30, 2025 was impacted by the recording of a tax benefit stemming from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner of $ 100 million and a tax benefit of $ 20 million related to the sale of an additional portion of the… +1 more paragraph
- The Company sought a refund of the withholding tax and, in the third quarter of 2026, the Company received the full refund from the CRA, equivalent to $ 318 million U.S. dollars.
- The credit for income taxes in the third quarter of 2025 was impacted by the recording of a tax benefit stemming from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner of $100 million and a tax benefit of $20 million related to the sale of an additional portion of the Company's membership… +1 more paragraph
Similar companies
Same SIC code (2821) and public float not reported.